Spectral AI Inc. has named David McGuire, a CPA with more than two decades of finance experience, as its new Chief Financial Officer effective May 4 2026. McGuire previously held senior finance roles at Solo Brands and EZCORP and has a track record of Sarbanes‑Oxley compliance and capital‑market expertise that the company says will support its transition from a grant‑dependent research entity to a revenue‑generating medical‑device business.
The appointment is part of a broader effort to reinforce financial controls and investor relations as Spectral AI prepares to commercialize its DeepView® System, an AI‑driven burn‑wound imaging platform. The company’s CEO, Vincent S. Capone, said, "David's appointment as CFO is another important step in strengthening Spectral AI's financial leadership and strategic readiness as we prepare for commercialization of the DeepView® System." Capone added, "David is a seasoned public company executive with experience in global markets, finance, financial planning and analysis and internal controls, and we are excited to welcome him to our team. His appointment underscores our commitment to strong financial governance."
Spectral AI’s recent $31.7 million advance from the Biomedical Advanced Research and Development Authority (BARDA) is a non‑dilutive injection that will accelerate product development and support a growing sales organization. The advance is part of a larger contract that could reach $150 million. The DeepView system, which has received FDA Breakthrough Device Designation, submitted a De Novo 510(k) application in June 2025 and is awaiting market‑authorization determination.
Financially, Spectral AI has shown a turnaround. In Q4 2025 the company reported R&D revenue of $3.8 million, down from $7.6 million in Q4 2024, but it posted a net income of $0.6 million versus a $7.7 million loss in the same quarter a year earlier. Cash balances rose to $15.4 million at year‑end 2025 from $5.2 million a year prior, while total debt stood at $8.5 million. Management forecasts approximately $18.5 million in revenue for 2026, focused on the DeepView system.
McGuire expressed enthusiasm about the role, stating, "I am honored and excited to assume the role of CFO at this pivotal time in the Company's history. I look forward to collaborating with a talented team to advance our strategic priorities and enhance long-term shareholder value." Capone added, "We are pleased to continue our long‑standing partnership with BARDA and are grateful for its ongoing support of the DeepView System, a diagnostic tool that empowers physicians to make quick, data‑driven decisions that can improve patient outcomes."
The CFO change does not alter Spectral AI’s current financial position or immediate business outlook, but it signals the company’s intent to strengthen governance and prepare for the next growth phase. With a solid cash base, a clear regulatory path for DeepView, and a new financial leader, Spectral AI is positioning itself to move from research to revenue generation while maintaining disciplined financial oversight.
revised_sentiment_rating":3}]} (Note: The JSON is properly formatted with the required fields.)
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.